NF-κB and p53 Are the Dominant Apoptosis-inducing Transcription Factors Elicited by the HIV-1 Envelope

The coculture of cells expressing the HIV-1 envelope glycoprotein complex (Env) with cells expressing CD4 results into cell fusion, deregulated mitosis, and subsequent cell death. Here, we show that NF-κB, p53, and AP1 are activated in Env-elicited apoptosis. The nuclear factor κB (NF-κB) super repressor had an antimitotic and antiapoptotic effect and prevented the Env-elicited phosphorylation of p53 on serine 15 and 46, as well as the activation of AP1. Transfection with dominant-negative p53 abolished apoptosis and AP1 activation. Signs of NF-κB and p53 activation were also detected in lymph node biopsies from HIV-1–infected individuals. Microarrays revealed that most (85%) of the transcriptional effects of HIV-1 Env were blocked by the p53 inhibitor pifithrin-α. Macroarrays led to the identification of several Env-elicited, p53-dependent proapoptotic transcripts, in particular Puma, a proapoptotic “BH3-only” protein from the Bcl-2 family known to activate Bax/Bak. Down modulation of Puma by antisense oligonucleotides, as well as RNA interference of Bax and Bak, prevented Env-induced apoptosis. HIV-1–infected primary lymphoblasts up-regulated Puma in vitro. Moreover, circulating CD4+ lymphocytes from untreated, HIV-1–infected donors contained enhanced amounts of Puma protein, and these elevated Puma levels dropped upon antiretroviral therapy. Altogether, these data indicate that NF-κB and p53 cooperate as the dominant proapoptotic transcription factors participating in HIV-1 infection.

[1]  K. Vousden,et al.  PUMA, a novel proapoptotic gene, is induced by p53. , 2001, Molecular cell.

[2]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.

[3]  M. Magnani,et al.  Unscheduled cyclin B expression and p34 cdc2 activation in T lymphocytes from HIV-infected patients. , 1999, AIDS.

[4]  J. Corbeil,et al.  HIV induces lymphocyte apoptosis by a p53‐initiated, mitochondrial‐mediated mechanism , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  V. Vullo,et al.  Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy , 2000, AIDS.

[6]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[7]  J. Barretina,et al.  Human Immunodeficiency Virus 1 Envelope Glycoprotein Complex-Induced Apoptosis Involves Mammalian Target of Rapamycin/Fkbp12-Rapamycin–Associated Protein–Mediated P53 Phosphorylation , 2001, The Journal of experimental medicine.

[8]  Andreas Villunger,et al.  p53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa , 2003, Science.

[9]  A. Badley,et al.  Mechanisms of HIV-associated lymphocyte apoptosis. , 2000, Blood.

[10]  Jerome H. Kim,et al.  HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: a potential mechanism of G2/M cell cycle arrest. , 2003, Virology.

[11]  A. Badley,et al.  Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. , 2003, The Journal of clinical investigation.

[12]  J. Alimonti,et al.  Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. , 2003, The Journal of general virology.

[13]  A. di Caro,et al.  Susceptibility to highly sulphated glycosaminoglycans of human immunodeficiency virus type 1 replication in peripheral blood lymphocytes and monocyte-derived macrophages cell cultures. , 2003, Antiviral research.

[14]  G. Kroemer,et al.  Apoptosis and karyogamy in syncytia induced by the HIV-1-envelope glycoprotein complex , 2000, Cell Death and Differentiation.

[15]  B. Pützer,et al.  Role of the p53-homologue p73 in E2F1-induced apoptosis , 2000, Nature Genetics.

[16]  D. Ingber,et al.  Apoptosis of syncytia induced by the HIV-1-envelope glycoprotein complex: influence of cell shape and size. , 2000, Experimental cell research.

[17]  H. Lecoeur,et al.  Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis. , 1998, Journal of immunology.

[18]  A. Fauci,et al.  Apoptosis in HIV infection , 1995, Nature Medicine.

[19]  K. Kinzler,et al.  PUMA induces the rapid apoptosis of colorectal cancer cells. , 2001, Molecular cell.

[20]  Guido Kroemer,et al.  Mitochondrio‐nuclear translocation of AIF in apoptosis and necrosis , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  G. Kroemer,et al.  The mitochondriotoxic domain of Vpr determines HIV-1 virulence. , 2003, The Journal of clinical investigation.

[22]  Xin Lu,et al.  Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.

[23]  J. Corbeil,et al.  Productive HIV-1 Infection of Primary CD4+ T Cells Induces Mitochondrial Membrane Permeabilization Leading to a Caspase-independent Cell Death* , 2002, The Journal of Biological Chemistry.

[24]  Yusuke Nakamura,et al.  p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53 , 2000, Cell.

[25]  S. Steinberg,et al.  Apoptosis and apoptosis‐associated perturbations of peripheral blood lymphocytes during HIV infection: comparison between AIDS patients and asymptomatic long‐term non‐progressors , 2000, Clinical and experimental immunology.

[26]  Christian Kaltschmidt,et al.  Repression of NF-κB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators , 1999, Oncogene.

[27]  J Leibowitch,et al.  Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. , 1997, Science.

[28]  John Calvin Reed,et al.  Identification of a p53-dependent negative response element in the bcl-2 gene. , 1994, Cancer research.

[29]  Guido Kroemer,et al.  Control of Mitochondrial Membrane Permeabilization by Adenine Nucleotide Translocator Interacting with HIV-1 Viral Protein R and Bcl-2 , 2001, The Journal of experimental medicine.

[30]  J. Barretina,et al.  Cell-surface-expressed HIV-1 envelope induces the death of CD4 T cells during GP41-mediated hemifusion-like events. , 2003, Virology.

[31]  Michael Karin,et al.  NF-kappaB in cancer: from innocent bystander to major culprit. , 2002, Nature reviews. Cancer.

[32]  K. Kinzler,et al.  PUMA mediates the apoptotic response to p53 in colorectal cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. van den Heuvel,et al.  Distinct roles for cyclin-dependent kinases in cell cycle control. , 1993, Science.

[34]  G. Kroemer,et al.  Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe , 2002, Cell Death and Differentiation.

[35]  H. Keller,et al.  Involvement of Bcl-2 and IL-2R in HIV-positive patients whose CD4 cell counts fail to increase rapidly with highly active antiretroviral therapy , 2002, AIDS.

[36]  G. Kroemer,et al.  Apoptosis Control in Syncytia Induced by the HIV Type 1–Envelope Glycoprotein Complex , 2000, The Journal of experimental medicine.

[37]  Donald E Ingber,et al.  Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV‐1 envelope , 2002, The EMBO journal.

[38]  A. Smahi,et al.  The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. , 2002, Human molecular genetics.

[39]  M. Gougeon,et al.  Cell death and immunity: Apoptosis as an HIV strategy to escape immune attack , 2003, Nature Reviews Immunology.

[40]  A. Baldwin,et al.  p53 Transactivation of the HIV-1 Long Terminal Repeat Is Blocked by PD 144795, a Calcineurin-Inhibitor with Anti-HIV Properties* , 1998, The Journal of Biological Chemistry.

[41]  John Calvin Reed,et al.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.